These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 1479161)

  • 21. Controlled clinical trials of omeprazole in the long-term management of reflux disease.
    Hetzel DJ
    Digestion; 1992; 51 Suppl 1():35-42. PubMed ID: 1397745
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 24-hour intragastric acidity and plasma gastrin during long-term treatment with omeprazole or ranitidine in patients with reflux esophagitis.
    Lind T; Cederberg C; Idström JP; Lönroth H; Olbe L; Lundell L
    Scand J Gastroenterol; 1991 Jun; 26(6):620-6. PubMed ID: 1862300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Double blind multicentre comparison of omeprazole 20 mg once daily versus ranitidine 150 mg twice daily in the treatment of cimetidine or ranitidine resistant duodenal ulcers.
    Delchier JC; Isal JP; Eriksson S; Soule JC
    Gut; 1989 Sep; 30(9):1173-8. PubMed ID: 2680793
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention of relapse of reflux oesophagitis after endoscopic healing: the efficacy and safety of omeprazole compared with ranitidine.
    Lundell L
    Digestion; 1990; 47 Suppl 1():72-5. PubMed ID: 2093020
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Maintenance therapy for erosive esophagitis in children after healing by omeprazole: is it advisable?
    Boccia G; Manguso F; Miele E; Buonavolontà R; Staiano A
    Am J Gastroenterol; 2007 Jun; 102(6):1291-7. PubMed ID: 17319927
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical superiority of pantoprazole over ranitidine in the treatment of reflux esophagitis grade II and III. A prospective, double-blind, double-placebo study. Mexican clinical experience. Mexican Pantoprazole Study Group].
    Gallo S; Dibildox M; Moguel A; Di Silvio M; Rodríguez F; Almaguer I; García C
    Rev Gastroenterol Mex; 1998; 63(1):11-6. PubMed ID: 10068743
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of omeprazole in the long-term treatment of peptic ulcer and reflux oesophagitis resistant to ranitidine.
    Brunner GH; Lamberts R; Creutzfeldt W
    Digestion; 1990; 47 Suppl 1():64-8; discussion 76. PubMed ID: 2093018
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Prognostic factors influencing healing of reflux esophagitis. A controlled trial of omeprazole versus ranitidine. Study group Omega].
    Barbier JP; Haccoun P; Bergmann JF; Arnould B; Hamelin B
    Ann Gastroenterol Hepatol (Paris); 1993; 29(4):213-8. PubMed ID: 8239492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Histamine H2 receptor antagonist-refractory oesophagitis: the efficacy of long-term omeprazole maintenance treatment.
    Bardhan KD; Cherian P; Jones RB; Vaishnavi A; Manek S; Bishop A; Polak J; Brooks A; Morris P; Thompson M; D'Silva J; Parkin S; Patterson J; Gillon KR
    Ital J Gastroenterol Hepatol; 1997 Dec; 29(6):515-9. PubMed ID: 9513825
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Comparison of the cost-efficacy ratio of omeprazole and ranitidine in the treatment of reflux esophagitis].
    Bergmann JF; Hamelin B; Barbier JP
    Gastroenterol Clin Biol; 1995 May; 19(5):482-6. PubMed ID: 7589999
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and tolerability of pantoprazole versus ranitidine in the treatment of reflux esophagitis and the influence of Helicobacter pylori infection on healing rate.
    Meneghelli UG; Boaventura S; Moraes-Filho JP; Leitão O; Ferrari AP; Almeida JR; Magalhães AF; Castro LP; Haddad MT; Tolentino M; Jorge JL; Silva E; Maguilnik I; Fischer R
    Dis Esophagus; 2002; 15(1):50-6. PubMed ID: 12060043
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High doses of ranitidine in patients with reflux oesophagitis.
    Jansen JB; Lamers CB
    Scand J Gastroenterol Suppl; 1990; 178():42-6. PubMed ID: 2277968
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lansoprazole compared with ranitidine for the treatment of nonerosive gastroesophageal reflux disease.
    Richter JE; Campbell DR; Kahrilas PJ; Huang B; Fludas C
    Arch Intern Med; 2000 Jun; 160(12):1803-9. PubMed ID: 10871974
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of five maintenance therapies for reflux esophagitis.
    Vigneri S; Termini R; Leandro G; Badalamenti S; Pantalena M; Savarino V; Di Mario F; Battaglia G; Mela GS; Pilotto A
    N Engl J Med; 1995 Oct; 333(17):1106-10. PubMed ID: 7565948
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Different healing tendencies of reflux esophagitis following omeprazole and ranitidine. Results of a German-Austrian-Swiss multicenter study].
    Dammann HG; Blum AL; Lux G; Rehner M; Riecken EO; Schiessel R; Wienbeck M; Witzel L; Berger J
    Dtsch Med Wochenschr; 1986 Jan; 111(4):123-8. PubMed ID: 3510847
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Omeprazole is superior to ranitidine plus metoclopramide in the short-term treatment of erosive oesophagitis.
    Robinson M; Decktor DL; Maton PN; Sabesin S; Roufail W; Kogut D; Roberts W; McCullough A; Pardoll P; Saco L
    Aliment Pharmacol Ther; 1993 Feb; 7(1):67-73. PubMed ID: 8439639
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized blinded comparison of omeprazole and ranitidine in the treatment of chronic esophageal stricture secondary to acid peptic esophagitis.
    Silvis SE; Farahmand M; Johnson JA; Ansel HJ; Ho SB
    Gastrointest Endosc; 1996 Mar; 43(3):216-21. PubMed ID: 8857137
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Short and long-term effect of two different dosages of ranitidine in the therapy of reflux oesophagitis.
    Pace F; Sangaletti O; Bianchi Porro G
    Ital J Gastroenterol; 1990 Feb; 22(1):28-32. PubMed ID: 2131925
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Omeprazole treatment of children with peptic esophagitis refractory to ranitidine therapy.
    Karjoo M; Kane R
    Arch Pediatr Adolesc Med; 1995 Mar; 149(3):267-71. PubMed ID: 7858685
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of omeprazole and histamine H2-receptor antagonists in the treatment of elderly and young patients with reflux oesophagitis.
    James OF; Parry-Billings KS
    Age Ageing; 1994 Mar; 23(2):121-6. PubMed ID: 8023719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.